NCT00030030View on ClinicalTrials.gov

Evaluating Silymarin for Chronic Hepatitis C

PHASE2CompletedINTERVENTIONAL

Timeline

Start Date

July 31, 2000

Study Completion Date

June 30, 2002

Conditions

Hepatitis C, Chronic

Interventions

DRUG

Silymarin (milk thistle)

All Listed Sponsors

collaborator

Office of Dietary Supplements (ODS)

NIH

lead

National Center for Complementary and Integrative Health (NCCIH)

NIH

NCT00030030 - Evaluating Silymarin for Chronic Hepatitis C | Biotech Hunter | Biotech Hunter